We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search

Congress Abstract

Cetuximab as last-line treatment for rmHNSCC outside clinical trials. A retrospective DAHANCA study

i Login to view item